DANAHER Stock Other OTC
Stocks
US2358513008
Advanced Medical Equipment & Technology
| Market Cap | 128B 110B 102B 95.48B 179B 12,126B 181B 1,199B 468B 5,933B 481B 471B 20,558B | P/E Ratio 2026 * |
28.9x | P/E Ratio 2027 * | 22.9x |
|---|---|---|---|---|---|
| Enterprise Value | 137B 118B 109B 102B 192B 12,980B 194B 1,284B 501B 6,351B 515B 504B 22,006B | EV / Sales 2026 * |
5.25x | EV / Sales 2027 * | 4.66x |
| Free-Float |
71.13% | Yield 2026 * |
0.79% | Yield 2027 * | 0.85% |
Last Transcript: DANAHER
| 1 day | +0.07% |
| Manager | Title | Age | Since |
|---|---|---|---|
Rainer Blair
CEO | Chief Executive Officer | 62 | 2020-08-31 |
Matthew Gugino
DFI | Director of Finance/CFO | - | 2026-02-27 |
Steven Dee
CTO | Chief Tech/Sci/R&D Officer | - | 2025-08-24 |
| Director | Title | Age | Since |
|---|---|---|---|
Alan Spoon
BRD | Director/Board Member | 74 | 1999-06-30 |
Steven Rales
CHM | Chairman | 74 | 1983-12-31 |
Mitchell Rales
BRD | Director/Board Member | 69 | 1983-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.07% | -1.98% | - | - | 128B | ||
| -0.23% | +0.64% | +17.35% | -11.68% | 176B | ||
| +0.12% | -0.37% | -18.57% | +27.05% | 148B | ||
| +0.34% | -3.66% | -52.96% | -13.08% | 69.5B | ||
| +2.67% | +3.18% | +17.87% | -2.97% | 49.68B | ||
| +0.97% | +2.71% | -22.67% | -32.79% | 45.26B | ||
| -1.72% | -3.28% | +9.62% | +5.86% | 36.88B | ||
| +0.78% | -0.77% | +5.33% | +34.48% | 35.13B | ||
| -2.36% | -2.23% | -12.48% | -20.06% | 29.46B | ||
| +0.62% | +0.41% | -22.22% | -11.43% | 27.84B | ||
| Average | +0.11% | -0.79% | -8.75% | -2.73% | 68.59B | |
| Weighted average by Cap. | +0.11% | -0.49% | -6.40% | -0.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 26.13B 22.51B 20.71B 19.46B 36.54B 2,472B 36.98B 244B 95.33B 1,209B 98.04B 95.96B 4,190B | 28.56B 24.61B 22.64B 21.28B 39.95B 2,702B 40.43B 267B 104B 1,322B 107B 105B 4,581B |
| Net income | 4.38B 3.78B 3.48B 3.27B 6.13B 415B 6.21B 41.02B 16B 203B 16.45B 16.1B 703B | 5.53B 4.76B 4.38B 4.12B 7.73B 523B 7.83B 51.73B 20.18B 256B 20.75B 20.31B 887B |
| Net Debt | 9.02B 7.77B 7.15B 6.72B 12.62B 854B 12.77B 84.42B 32.93B 418B 33.86B 33.14B 1,447B | 4.92B 4.24B 3.9B 3.67B 6.89B 466B 6.97B 46.07B 17.97B 228B 18.48B 18.09B 790B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

















